The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
antihemophilic factor (recombinant), glycopegylated-exei
10 marketed package NDCs · 1 active manufacturer
Most dispensed: Kit · #1 kit/kit * 4 ml in 1 vial, glass * 4 ml in 1 syringe, glass * 4 ml in 1 vial, glass · Kit · #1 kit/kit * 4 ml in 1 vial, glass * 4 ml in 1 syringe, glass
Common questions
- Is Antihemophilic factor (recombinant), glycopegylated-exei in shortage right now?
- No. FDA does not currently list Antihemophilic factor (recombinant), glycopegylated-exei in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Antihemophilic factor (recombinant), glycopegylated-exei?
- 1 company has marketed Antihemophilic factor (recombinant), glycopegylated-exei in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.